Global arms makers see record earnings as Gaza, Ukraine wars fuel demand — report

Global sales by the top 100 arms makers hit a record $679 billion in 2024, up 5.9% year-on-year and 26% over 2015-24, as the Ukraine and Gaza wars boosted demand. US firms dominate (39 firms; $334 billion, +3.8%), European firms (26 firms) grew 13% to $151 billion, while Asia & Oceania fell 1.2% to $130 billion; nine Middle East firms generated $31 billion with three Israeli companies accounting for $16.2 billion (+16%). Supply-chain and production constraints — including F‑35 and submarine program delays, loss of Russian titanium supplies and Chinese export restrictions on critical minerals — may limit deliveries and raise costs despite stronger revenues, creating upside for defense equities but with operational and geopolitical risk.

Analysis

Market structure: The SIPRI data (top-100 arms sales +5.9% to $679bn; US firms $334bn ~49%, Europe +13% to $151bn) implies durable demand concentration in large prime contractors (Lockheed LMT, RTX, NOC) and European systems integrators. Winners are primes with backlogs and sovereign export lines; losers are small sub-contractors and OEMs exposed to bottlenecked inputs (titanium, critical minerals) or Chinese procurement freezes. Pricing power should rise for capacity owners but margin pressure will appear where raw-material sourcing shifts increase input costs by an incremental 5-15% for titanium/critical-mineral‑intensive platforms over 12–24 months.

Risk assessment: Tail risks include a swift regional ceasefire or major procurement cancellations (Ukraine/Gaza de-escalation) wiping 10–20% off near‑term order flow, or new export controls that freeze supply chains and delay deliveries (F-35/Columbia overruns). Near-term (days–weeks) volatility will hinge on contract announcements and budget votes; medium (3–12 months) risks are supply-chain inflation and labor constraints; long-term (2–5 years) outcomes depend on sustained NATO/EU rearmament budgets. Hidden dependencies: primes rely on single-source specialty inputs (Russian/Chinese origins), and idiosyncratic program overruns can dwarf organic growth.

Trade implications: Favor large-cap U.S. primes with deep backlog—consider 2–4% portfolio longs in LMT and RTX with 6–12 month horizon to capture margin and order-book re-rating; use NOC as a defensive component but watch program risk. Hedge commodity exposure by buying 3–6 month call spreads on critical-minerals proxies or adding tactical long positions in titanium/aluminum suppliers if realized input‑cost inflation exceeds 7%. Fixed income: modestly underweight long-duration sovereign bonds (expect higher deficits) and buy protection (HY CDS) on small-cap defense contractors with >20% revenue dependence on a single program.

Contrarian angles: Consensus prizes revenue growth but underestimates margin squeezes from supply re-shoring and commodity constraints—this creates opportunity to short mid-cap subcontractors whose bid margins compress >200bps over 12 months. Also overlooked: reputational/political risk has not dented demand for Israeli systems—this suggests selective longs in Israeli-exposed primes and defense-tech niche software firms where geopolitical premium is priced-in but not fully reflected. Historical parallel: post-2008 surge in defense budgets saw 12–18 month lags between order authorizations and revenue; expect similar lag now — front‑loading exposure ahead of visible bookings is higher-risk but higher-reward.

Key Decisions for Investors

• Establish a 2–4% long position in RTX (6–12 month horizon) funded by trimming broader industrial cyclicals; consider buying a 9-month bull call spread (buy 1 ATM call, sell 1.25x strike) to limit cost while capturing upside from order wins and margin recovery.
• Add a 2% long position in LMT (12-month horizon) and sell 1–2% covered calls with 6–9 month expiries at ~5–10% out-of-the-money to monetize elevated implied volatility while retaining upside to new contract awards.
• Initiate a tactical 1–2% short on a mid-cap European/EM defense subcontractor (select names with >40% revenue from single programs) — target names where >200bp margin compression is likely; place stop-loss at 8–10% to limit idiosyncratic risk.
• Reduce duration in core fixed-income by 0.5–1 year and rotate 1–2% of portfolio into commodity exposure (physical/ETFs) for titanium/critical minerals if input-cost inflation signals exceed +7% over a rolling 3-month window.
• Monitor these catalysts over the next 30–90 days: EU/NATO budget votes, major contract awards (F-35, Columbia, Rheinmetall orders), and Chinese export-policy announcements — only deploy incremental capital on confirmed multi-year procurement commitments or visible backlog growth >10% q/q.